Suppr超能文献

作为用于成像5-羟色胺摄取位点的放射性示踪剂的高效茚胺5-羟色胺摄取阻滞剂。

Highly potent indanamine serotonin uptake blockers as radiotracers for imaging serotonin uptake sites.

作者信息

Suehiro M, Scheffel U A, Ravert H T, Ricaurte G A, Hatzidimitriou G, Dannals R F, Bøgesø K P, Wagner H N

机构信息

Division of Nuclear Medicine, Johns Hopkins Medical Institutions, Baltimore, MD 21205, USA.

出版信息

Nucl Med Biol. 1994 Nov;21(8):1083-91. doi: 10.1016/0969-8051(94)90180-5.

Abstract

Two highly potent indanamine serotonin (5-HT) uptake blockers, trans-3'-(4'-bromophenyl)-1-indanamine (trans-[11C]DBPI or [11C]Lu 19-056) and its iodo analog, trans-3'(4'-[125I]iodophenyl)-1-indanamine (trans-[125I]DIPI) were evaluated as radiotracers for imaging 5-HT uptake sites in vivo Trans-[11C]DBPI was synthesized by N-methylation of the normethyl precursor with [11C]iodomethane. Trans-[125I]DIPI was synthesized by iododestannylation of the tributyltin precursor with [125I]NaI. Radiochemical yields for the [11C] and [125I] radiotracers were 34 and 40% with specific activities of 4000 and 1800 mCi/mumol, respectively. In vitro, the iodo analog, trans-DIPI, showed an IC50 value of 0.26 nM in inhibition of [3H]paroxetine binding to 5-HT uptake sites in rat cortex. The potency was found to be equivalent to that of paroxetine or McN5652. In vivo, after i.v. injection into mice, both radiotracers showed high uptake in brain (3-4% dose/whole brain at 15 min) and high accumulation into target tissues such as hypothalamus and olfactory tubercles (7-8% dose/g at 60 min). The binding was blocked by pre-injection of 5 mg/kg of peroxetine. While the in vivo distribution agreed with previously reported 5-HT uptake site distribution, the radiotracers showed high uptake in non-target tissues such as cerebellum, resulting in low target-to-non-target ratios (1.5-1.6 at 60 min). Since washout from non-target regions was slower than from target regions, longer-time observation with 125I up to 6 h did not improve the ratios. HPLC analyses of mouse brain homogenates and blocking studies indicated that the high uptake in non-target regions is not the result of metabolism or any interaction of the radiotracers with those tissues via specific binding sites. In spite of low target-to-non-target ratios, target regions with high density of 5-HT uptake sites, such as the raphe nuclei, superior colliculi and substantia nigra, were visualized with trans-[125I]DIPI by ex vivo autoradiography, since the radiotracer showed high specific binding (total mimus nonspecific binding).

摘要

两种高效的茚胺类血清素(5-羟色胺,5-HT)摄取阻滞剂,反式-3'-(4'-溴苯基)-1-茚胺(反式-[11C]DBPI或[11C]Lu 19-056)及其碘类似物,反式-3'(4'-[125I]碘苯基)-1-茚胺(反式-[125I]DIPI),被评估作为体内成像5-HT摄取位点的放射性示踪剂。反式-[11C]DBPI通过用[11C]碘甲烷对去甲基前体进行N-甲基化来合成。反式-[125I]DIPI通过用[125I]NaI对三丁基锡前体进行碘脱锡反应来合成。[11C]和[125I]放射性示踪剂的放射化学产率分别为34%和40%,比活分别为4000和1800 mCi/μmol。在体外,碘类似物反式-DIPI在抑制[3H]帕罗西汀与大鼠皮层中5-HT摄取位点结合方面显示出IC50值为0.26 nM。发现其效力与帕罗西汀或McN5652相当。在体内,静脉注射到小鼠体内后,两种放射性示踪剂在脑中均显示出高摄取(15分钟时为3 - 4%剂量/全脑),并在靶组织如下丘脑和嗅结节中高度蓄积(60分钟时为7 - 8%剂量/克)。预先注射5 mg/kg的帕罗西汀可阻断这种结合。虽然体内分布与先前报道的5-HT摄取位点分布一致,但放射性示踪剂在非靶组织如小脑中显示出高摄取,导致靶与非靶比值较低(60分钟时为1.5 - 1.6)。由于从非靶区域的洗脱比从靶区域慢,用125I长达6小时的更长时间观察并未改善比值。对小鼠脑匀浆的HPLC分析和阻断研究表明,非靶区域的高摄取不是放射性示踪剂通过特异性结合位点与这些组织发生代谢或任何相互作用的结果。尽管靶与非靶比值较低,但通过离体放射自显影,反式-[125I]DIPI仍能使5-HT摄取位点高密度的靶区域如中缝核、上丘和黑质可视化,因为该放射性示踪剂显示出高特异性结合(总结合减去非特异性结合)。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验